{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T11:21:33Z","timestamp":1785583293504,"version":"3.56.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sleep Breath"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s11325-025-03553-3","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T13:24:24Z","timestamp":1765373064000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Can sacubitril\/valsartan enhance sleep quality and reduce daytime dysfunction in HFrEF patients?"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0090-3835","authenticated-orcid":false,"given":"Se\u00e7kin","family":"Dereli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5164-8312","authenticated-orcid":false,"given":"Onur Osman","family":"\u015eeker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"3553_CR1","doi-asserted-by":"publisher","DOI":"10.21037\/amj.2020.03.03","author":"G Lippi","year":"2020","unstructured":"Lippi G, Sanchis-Gomar F (2020) Global epidemiology and future trends of heart failure. AME Med J. https:\/\/doi.org\/10.21037\/amj.2020.03.03","journal-title":"AME Med J"},{"issue":"2","key":"3553_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10741-021-10135-4","volume":"27","author":"J Beezer","year":"2022","unstructured":"Beezer J, Al Hatrushi M, Husband A, Kurdi A, Forsyth P (2022) Polypharmacy definition and prevalence in heart failure: a systematic review. Heart Fail Rev 27(2):465\u2013492","journal-title":"Heart Fail Rev"},{"issue":"12","key":"3553_CR3","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1056\/NEJMoa1506459","volume":"373","author":"MR Cowie","year":"2015","unstructured":"Cowie MR, Woehrle H, Wegscheider K, Angermann C, d\u2019Ortho M-P, Erdmann E et al (2015) Adaptive servo-ventilation for central sleep apnea in systolic heart failure. N Engl J Med 373(12):1095\u20131105","journal-title":"N Engl J Med"},{"issue":"3","key":"3553_CR4","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/ehf2.12659","volume":"7","author":"S Lee","year":"2020","unstructured":"Lee S, Oh J, Kim H, Ha J, Chun Kh, Lee CJ et al (2020) Sacubitril\/valsartan in patients with heart failure with reduced ejection fraction with end-stage of renal disease. ESC Heart Fail 7(3):1125\u20139","journal-title":"ESC Heart Fail"},{"key":"3553_CR5","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.943529","volume":"30","author":"Ze Yao","year":"2024","unstructured":"Yao Ze, Wang P, Fu Q, Song Q, Liu A, Li H et al (2024) Efficacy and safety of sacubitril\/valsartan in hemodialysis patients with chronic heart failure: a retrospective study at a single center. Med Sci Monit 30:e943529-1","journal-title":"Med Sci Monit"},{"issue":"Suppl1","key":"3553_CR6","first-page":"A4140053","volume":"150","author":"Y Ahn","year":"2024","unstructured":"Ahn Y, Jung M-H, Youn J-C, Cho D-H, Choi J, Yoo B-S (2024) Effect of Sacubitril\/Valsartan in patients with concomitant heart failure with reduced ejection fraction and End-Stage renal disease on Hemodialysis. Circulation 150(Suppl1):A4140053\u2013A","journal-title":"Circulation"},{"issue":"4","key":"3553_CR7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.recesp.2023.10.021","volume":"77","author":"Comments on","year":"2024","unstructured":"Comments on (2024) The 2023 update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Rev Esp Cardiol (Engl Ed) 77(4):281\u2013284","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"3553_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2025.01.004","author":"JJ Barboza","year":"2025","unstructured":"Barboza JJ, Le\u00f3n-Figueroa DA, Pasupuleti V, Piscoya A, Roman YM, Valenzuela-Rodriguez G et al (2025) Effects of sacubitril\/Valsartan on renal function in adults with heart failure: a systematic review and meta-analysis of randomised controlled trials. Heart Lung Circ. https:\/\/doi.org\/10.1016\/j.hlc.2025.01.004","journal-title":"Heart Lung Circ"},{"key":"3553_CR9","doi-asserted-by":"publisher","unstructured":"Bauersachs J, Soltani S (2022) Guidelines of the ESC 2021 on heart failure. Herz (1):7. https:\/\/doi.org\/10.1007\/s00059-021-05084-5","DOI":"10.1007\/s00059-021-05084-5"},{"key":"3553_CR10","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s40256-020-00440-y","volume":"21","author":"RM Khandwalla","year":"2021","unstructured":"Khandwalla RM, Grant D, Birkeland K, Heywood JT, Fombu E, Owens RL et al (2021) The AWAKE-HF study: sacubitril\/valsartan impact on daily physical activity and sleep in heart failure. Am J Cardiovasc Drugs 21:241\u2013254","journal-title":"Am J Cardiovasc Drugs"},{"issue":"3","key":"3553_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. European Heart Journal-Cardiovascular Imaging 16(3):233\u201371","journal-title":"European Heart Journal-Cardiovascular Imaging"},{"issue":"2","key":"3553_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds IIICF, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatr Res 28(2):193\u2013213","journal-title":"Psychiatr Res"},{"issue":"6","key":"3553_CR13","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14(6):540\u2013545","journal-title":"Sleep"},{"issue":"3","key":"3553_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s11739-008-0130-6","volume":"3","author":"C Rostagno","year":"2008","unstructured":"Rostagno C, Gensini GF (2008) Six minute walk test: a simple and useful test to evaluate functional capacity in patients with heart failure. Intern Emerg Med 3(3):205\u2013212","journal-title":"Intern Emerg Med"},{"key":"3553_CR15","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s11897-017-0330-3","volume":"14","author":"H Du","year":"2017","unstructured":"Du H, Wonggom P, Tongpeth J, Clark RA (2017) Six-minute walk test for assessing physical functional capacity in chronic heart failure. Curr Heart Fail Rep 14:158\u2013166","journal-title":"Curr Heart Fail Rep"},{"issue":"2","key":"3553_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/jep.12629","volume":"23","author":"RW Bohannon","year":"2017","unstructured":"Bohannon RW, Crouch R (2017) Minimal clinically important difference for change in 6-minute walk test distance of adults with pathology: a systematic review. J Eval Clin Pract 23(2):377\u2013381","journal-title":"J Eval Clin Pract"},{"issue":"2","key":"3553_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ejhf.3081","volume":"26","author":"D Tomasoni","year":"2024","unstructured":"Tomasoni D, Pagnesi M, Colombo G, Chiarito M, Stolfo D, Baldetti L et al (2024) Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: an analysis from the HELP\u2010HF registry. Eur J Heart Fail 26(2):327\u201337","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"3553_CR18","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3390\/jcm13061572","volume":"13","author":"S Kommu","year":"2024","unstructured":"Kommu S, Berg RL (2024) The efficacy and safety of Sacubitril\/Valsartan compared to valsartan in patients with heart failure and mildly reduced and preserved ejection fractions: a systematic review and meta-analysis of randomized controlled trials. J Clin Med 13(6):1572","journal-title":"J Clin Med"},{"key":"3553_CR19","doi-asserted-by":"publisher","first-page":"1347908","DOI":"10.3389\/fcvm.2024.1347908","volume":"11","author":"FM Sarullo","year":"2024","unstructured":"Sarullo FM, Nugara C, Sarullo S, Iacoviello M, Di Gesaro G, Miani D et al (2024) Effects of sacubitril\/valsartan on the functional capacity of real-world patients in italy: the REAL. IT study on heart failure with reduced ejection fraction. Front Cardiovasc Med 11:1347908","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"3553_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/anec.70081","volume":"30","author":"A Arzhangzadeh","year":"2025","unstructured":"Arzhangzadeh A, Nikoo MH, Haghjoo M, Rasekh F, Shojaei S, Mousavi A et al (2025) The effect of sacubitril\/valsartan on supraventricular and ventricular arrhythmias in patients with heart failure. Ann Noninvasive Electrocardiol 30(3):e70081","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"3553_CR21","doi-asserted-by":"crossref","unstructured":"Bhattacharjee P, Khan Z (2023) Sacubitril\/Valsartan in the treatment of heart failure with reduced ejection fraction focusing on the impact on the quality of life: A systematic review and meta-analysis of randomized clinical trials. Cureus 15(11)","DOI":"10.7759\/cureus.48674"},{"issue":"12","key":"3553_CR22","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.cardfail.2021.07.021","volume":"27","author":"RL Owens","year":"2021","unstructured":"Owens RL, Birkeland K, Heywood JT, Steinhubl SR, Dorn J, Grant D et al (2021) Sleep outcomes from AWAKE-HF: a randomized clinical trial of sacubitril\/valsartan vs enalapril in patients with heart failure and reduced ejection fraction. J Card Fail 27(12):1466\u201371","journal-title":"J Card Fail"},{"issue":"5","key":"3553_CR23","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1161\/CIRCULATIONAHA.119.044586","volume":"141","author":"SD Solomon","year":"2020","unstructured":"Solomon SD, Vaduganathan M, Claggett L, Packer B, Zile M, Swedberg M (2020) Sacubitril\/valsartan across the spectrum of ejection fraction in heart failure. Circulation 141(5):352\u2013361","journal-title":"Circulation"},{"key":"3553_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ijcard.2022.01.004","volume":"350","author":"E Carluccio","year":"2022","unstructured":"Carluccio E, Dini FL, Bitto R, Ciccarelli M, Correale M, D\u2019Agostino A et al (2022) Benefit from sacubitril\/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: an echocardiographic study. Int J Cardiol 350:62\u20138","journal-title":"Int J Cardiol"},{"issue":"3","key":"3553_CR25","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/15598276231211846","volume":"18","author":"YM Eshera","year":"2024","unstructured":"Eshera YM, Gavrilova L, Hughes JW (2024) Sleep is essential for cardiovascular health: an analytic review of the relationship between sleep and cardiovascular mortality. Am J Lifestyle Med 18(3):340\u2013350","journal-title":"Am J Lifestyle Med"},{"key":"3553_CR26","doi-asserted-by":"crossref","unstructured":"Gao J, Han L, Cao H, Luo X-Q, Xu L, Zhou Y et al (2024) Association between Insomnia Symptoms and Risk of Heart Failure: A Meta-analysis of Prospective Cohort Studies. medRxiv 03.20.24304651","DOI":"10.1101\/2024.03.20.24304651"},{"key":"3553_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsae084","author":"L He","year":"2024","unstructured":"He L, Ma T, Wang X, Cheng X, Bai Y (2024) Association between longitudinal change of sleep patterns and the risk of cardiovascular diseases. Sleep. https:\/\/doi.org\/10.1093\/sleep\/zsae084","journal-title":"Sleep"},{"key":"3553_CR28","doi-asserted-by":"publisher","first-page":"1250085","DOI":"10.3389\/fpubh.2024.1250085","volume":"12","author":"A Bener","year":"2024","unstructured":"Bener A, Morgul E, Toka\u00e7 M, Ventriglio A, Jordan TR (2024) Sleep quality, quality of life, fatigue, and mental health in COVID-19 post-pandemic T\u00fcrkiye: a cross-sectional study. Front Public Health 12:1250085","journal-title":"Front Public Health"},{"key":"3553_CR29","doi-asserted-by":"publisher","unstructured":"Qasrawi SO, BaHammam AS (2024) Role of sleep and sleep disorders in cardiometabolic risk: a review and update. Curr Sleep Med Rep (1):17. https:\/\/doi.org\/10.1007\/s40675-024-00276-x","DOI":"10.1007\/s40675-024-00276-x"},{"issue":"1","key":"3553_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jsmc.2015.10.007","volume":"11","author":"N Covassin","year":"2016","unstructured":"Covassin N, Singh P (2016) Sleep duration and cardiovascular disease risk: epidemiologic and experimental evidence. Sleep Med Clin 11(1):81\u201389","journal-title":"Sleep Med Clin"},{"issue":"5","key":"3553_CR31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.123.010568","volume":"17","author":"H Ning","year":"2024","unstructured":"Ning H, Perak AM, Siddique J, Wilkins JT, Lloyd-Jones DM, Allen NB (2024) Association between life\u2019s essential 8 cardiovascular health metrics with cardiovascular events in the cardiovascular disease lifetime risk pooling project. Circ Cardiovasc Qual Outcomes 17(5):e010568","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"3553_CR32","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1186\/s12889-024-18381-5","volume":"24","author":"PNO Addo","year":"2024","unstructured":"Addo PNO, Mundagowa PT, Zhao L, Kanyangarara M, Brown MJ, Liu J (2024) Associations between sleep duration, sleep disturbance and cardiovascular disease biomarkers among adults in the united States. BMC Public Health 24(1):947","journal-title":"BMC Public Health"},{"issue":"9","key":"3553_CR33","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/aje\/kws342","volume":"177","author":"PE Peppard","year":"2013","unstructured":"Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM (2013) Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 177(9):1006\u20131014","journal-title":"Am J Epidemiol"},{"issue":"2","key":"3553_CR34","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1513\/pats.200707-114MG","volume":"5","author":"DJ Eckert","year":"2008","unstructured":"Eckert DJ, Malhotra A (2008) Pathophysiology of adult obstructive sleep apnea. Proc Am Thorac Soc 5(2):144\u2013153","journal-title":"Proc Am Thorac Soc"},{"issue":"21","key":"3553_CR35","doi-asserted-by":"publisher","first-page":"7772","DOI":"10.3390\/ijerph17217772","volume":"17","author":"P Jorge-Samitier","year":"2020","unstructured":"Jorge-Samitier P, Durante A, Gea-Caballero V, Ant\u00f3n-Solanas I, Fern\u00e1ndez-Rodrigo MT, Ju\u00e1rez-Vela R (2020) Sleep quality in patients with heart failure in the Spanish population: a cross-sectional study. Int J Environ Res Public Health 17(21):7772","journal-title":"Int J Environ Res Public Health"},{"key":"3553_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14850","author":"AL Slade","year":"2024","unstructured":"Slade AL, McMullan C, Haque MS, Griffith S, Marley L, Quinn D et al (2024) Development of a quality of life measure for left ventricular assist device recipients using a mixed methods approach. ESC Heart Fail. https:\/\/doi.org\/10.1002\/ehf2.14850","journal-title":"ESC Heart Fail"},{"issue":"1","key":"3553_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13102-023-00803-3","volume":"16","author":"M Arezomand","year":"2024","unstructured":"Arezomand M, Dehghan M, Rigi ZE, Fatehi F, Shahrbabaki PM (2024) The effect of using a sports application on the quality of sleep in patients with heart failure: a randomized clinical trial study. BMC Sports Sci Med Rehabil 16(1):15","journal-title":"BMC Sports Sci Med Rehabil"},{"key":"3553_CR38","doi-asserted-by":"publisher","first-page":"1058998","DOI":"10.3389\/fcvm.2022.1058998","volume":"9","author":"SE Litwin","year":"2022","unstructured":"Litwin SE, East CA (2022) Assessing clinical and biomarker characteristics to optimize the benefits of sacubitril\/valsartan in heart failure. Front Cardiovasc Med 9:1058998","journal-title":"Front Cardiovasc Med"},{"key":"3553_CR39","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s40265-019-01181-2","volume":"79","author":"E Fabris","year":"2019","unstructured":"Fabris E, Merlo M, Rapezzi C, Ferrari R, Metra M, Frigerio M et al (2019) Sacubitril\/valsartan: updates and clinical evidence for a disease-modifying approach. Drugs 79:1543\u20131556","journal-title":"Drugs"},{"key":"3553_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.892460","volume":"13","author":"NH Mustafa","year":"2022","unstructured":"Mustafa NH, Jalil J, Zainalabidin S, Saleh MS, Asmadi AY, Kamisah Y (2022) Molecular mechanisms of sacubitril\/valsartan in cardiac remodeling. Front Pharmacol 13:892460","journal-title":"Front Pharmacol"},{"issue":"3","key":"3553_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000490734","volume":"97","author":"R Tamisier","year":"2019","unstructured":"Tamisier R, Bocquillon V, Treptow E, Destors M, Salvat M, Borrel E et al (2019) Prevalence and factors contributing to daytime and nocturnal hypoxemia in chronic heart failure patients. Respiration 97(3):213\u2013222","journal-title":"Respiration"},{"issue":"1","key":"3553_CR42","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12931-020-1284-7","volume":"21","author":"S Andr\u00e9","year":"2020","unstructured":"Andr\u00e9 S, Andreozzi F, Van Overstraeten C, Ben Youssef S, Bold I, Carlier S et al (2020) Cardiometabolic comorbidities in obstructive sleep apnea patients are related to disease severity, nocturnal hypoxemia, and decreased sleep quality. Respir Res 21(1):35","journal-title":"Respir Res"},{"issue":"1","key":"3553_CR43","doi-asserted-by":"publisher","first-page":"30","DOI":"10.32552\/2022.ActaMedica.645","volume":"53","author":"F I\u015f\u0131k","year":"2022","unstructured":"I\u015f\u0131k F, Ok\u015ful M, Aslan B, Ta\u015ftan E (2022) Evaluation of sleep quality with use of angiotensin receptor neprilysin inhibitor in patients with reduced ejection fraction heart failure. Acta Med 53(1):30\u201336","journal-title":"Acta Med"}],"container-title":["Sleep and Breathing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11325-025-03553-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11325-025-03553-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11325-025-03553-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T18:14:49Z","timestamp":1774462489000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11325-025-03553-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["3553"],"URL":"https:\/\/doi.org\/10.1007\/s11325-025-03553-3","relation":{},"ISSN":["1520-9512","1522-1709"],"issn-type":[{"value":"1520-9512","type":"print"},{"value":"1522-1709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ordu University Scientific Research Ethics Committee (Application No: BAEK-306, Decision No: 2023\/296) and conducted in accordance with the ethical standards of the institutional research committee and the 1964 Helsinki Declaration, including its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent to participate was obtained from all patients included in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable. This study does not include identifiable individual patient data, images, or videos.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Limited to\n                      AI-assisted copy-editing\n                      ; all scientific content is author-generated and fully verified by the authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI\/LLM transparency"}},{"value":"The authors declare that they have no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"6"}}